INQOVI
Live / Registered — Registered — Section 71 accepted (as of 03 Feb 2025)
What this means for you
Registered since 31 Jul 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79229519
- Registration number
- 5527182
- Mark type
- Stylized text
- Filed
- 26 Dec 2017
- Published for opposition
- 15 May 2018
- Registered
- 31 Jul 2018
- Attorney of record
- Caroline E. Bryce
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating cancer; pharmaceutical preparations for treating immune disorders; pharmaceutical preparations for treating hematological disorders
Owner
- TAIHO PHARMACEUTICAL CO., LTD., Chiyoda-ku Tokyo, JP
- Otsuka Pharmaceutical Co., Ltd., JP
- Otsuka Pharmaceutical Co., Ltd., JP
- Otsuka Pharmaceutical Co., Ltd., JP
Prosecution history
- 03 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 03 Feb 2025 — REGISTERED-SEC.71 ACCEPTED
- 03 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Jul 2024 — TEAS SECTION 71 RECEIVED
- 26 Mar 2024 — CHANGE OF OWNER RECEIVED FROM IB
- 28 Sept 2018 — NOTIFICATION PROCESSED BY IB
- 13 Sept 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 13 Sept 2018 — FINAL DISPOSITION PROCESSED
- 30 Aug 2018 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 31 Jul 2018 — REGISTERED-PRINCIPAL REGISTER
- 15 May 2018 — PUBLISHED FOR OPPOSITION
- 25 Apr 2018 — NOTICE OF PUBLICATION
- 09 Apr 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Apr 2018 — APPLICATION FILING RECEIPT MAILED
- 03 Apr 2018 — ASSIGNED TO EXAMINER